Related Experiment Video
Updated: Aug 3, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
[Paroxysmal dystonia as the first manifestation of multiple sclerosis]
Y Aladro Benito1, P Villagra Cocco, F Carrillo Padilla
1Servicio de Neurología, Hospital Ntra. Sra. del Pino, Las Palmas de Gran Canaria.
Revista Clinica Espanola
|June 1, 1993
Abstract:
We discuss the case of a patient with episodes of left unilateral paroxysmal dystonia as first manifestation of multiple sclerosis, secondary to a demyelinization lesion in posterior arm of right internal capsule, detected by nuclear magnetic resonance (NMR). These episodes diminished with carbamazepine at low doses.
Insights
Multiple sclerosis can initially present as paroxysmal dystonia. A brain lesion in the internal capsule was identified using nuclear magnetic resonance, and symptoms improved with carbamazepine.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Demyelination in the central nervous system can lead to a variety of neurological symptoms.
- Paroxysmal dystonia is characterized by sudden, involuntary muscle contractions.
Observation:
- A patient presented with recurrent episodes of left unilateral paroxysmal dystonia.
- This dystonia was the initial clinical manifestation of multiple sclerosis.
- A demyelinization lesion was identified in the posterior arm of the right internal capsule via nuclear magnetic resonance (NMR).
Findings:
- The patient's paroxysmal dystonia episodes were linked to a specific demyelinization lesion.
- Low-dose carbamazepine treatment resulted in a reduction of dystonic episodes.
- NMR imaging was crucial in diagnosing the underlying cause of the neurological symptoms.
Implications:
- This case highlights the diverse and sometimes unusual initial presentations of multiple sclerosis.
- Early diagnosis and targeted treatment, such as carbamazepine for dystonia, can improve patient outcomes.
- Understanding the relationship between specific lesions and symptoms aids in MS management and research.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...